Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids

Drug Testing and Analysis

Volumn 7, Issue 6, 2015, Pages 467-474

  Spinelli, Eliani ^a,b   Barnes, Allan J ^a   Young, Sheena ^a   Castaneto, Marisol S ^a   Martin, Thomas M ^c   Klette, Kevin L ^c   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c Office of the under Secretary of Defense for Personnel and Readiness   (United States)

Author keywords

ELISA; Immunoassay; Synthetic cannabinoids

Indexed keywords

BODY FLUIDS; IMMUNOLOGY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

CANNABINOIDS; DESIGNER DRUGS; ELISA; ELISA SCREENINGS; IMMUNOASSAY; PENTANOIC ACID; PERFORMANCE; PERFORMANCE CHARACTERISTICS; SCREENING ASSAYS; SYNTHETIC CANNABINOID;

EFFICIENCY;

CANNABINOID; DESIGNER DRUG;

ARTICLE; AUTOMATION; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; URINALYSIS; PROCEDURES; SUBSTANCE ABUSE; URINE;

CANNABINOIDS; CHROMATOGRAPHY, LIQUID; DESIGNER DRUGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIMIT OF DETECTION; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84930250948     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1702     Document Type: Article

References (16)

1. L. De Petrocellis, M.G. Cascio, V. Di Marzo. The endocannabinoid system: a general view and latest additions. Br. J. Pharmacol. 2004, 141, 765.
2. F. Rodriguez de Fonseca, I. Del Arco, F.J. Bermudez-Silva, A. Bilbao, A. Cippitelli, M. Navarro. The endocannabinoid system: physiology and pharmacology. Alcohol Alcohol. 2005, 40, 2.
3. K.A. Seely, J. Lapoint, J.H. Moran, L. Fattore. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 39, 234.
4. S.M.R. Gurney, K. S. Scott, S.L. Kacincko, B.C. Presley, B.K. Logan. Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci. Rev. 2014, 26, 53.
5. United Nations Office on Drugs and Crime (UNODC). Synthetic cannabinoids in herbal products. UNODC, United Nations, Vienna, Austria, 2011.
6. United Nations Office on Drugs and Crime (UNODC). The challenge of new psychoactive substances. UNODC, United Nations Publication, Vienna Austria, 2013.
7. D. Wild, ed. The Immunoassay Handbook, 3rd Edn, Elsevier Science, Elsevier Ltd, Kidlington, Oxford, UK. 2005.
8. W.C. Rodrigues, P. Catbagan, S. Rana, G. H. Wang, C. Moore. Detection of synthetic cannabinoids in oral fluid using ELISA and LC-MS-MS. J. Anal. Toxicol. 2013, 37, 526.
9. A. Arntson, B. Ofsa, D. Lancaster, J.R. Simon, M. McMullin, B. Logan. Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens. J. Anal. Toxicol. 2013, 37, 284.
10. A.J. Barnes, S.A. Young, E. Spinelli, T.M. Martin, K.L. Klette, M.A. Huestis. Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine. Forensic Sci. Int. 2014, 241C, 27.
11. R. Kronstrand, L. Brinkhagen, C. Birath-Karlsson, M. Roman, M. Josefsson. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine. Anal. Bioanal. Chem. 2014, 406, 3599.
12. A. Wohlfarth, K.B. Scheidweiler, X. Chen, H.F. Liu, M.A. Huestis. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search. Anal. Chem. 2013, 85, 3730.
13. B.K. Logan. Testing strategies to monitor novel/emerging/designer drug use in at-risk populations. Presented at the 74th Annual CPPD, Palm Springs, CA. June 9-14, 2012.
14. Drug Enforcement Administration, Department of Justice. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order. Fed. Regist. 2011, 76, 65371.
15. L. Ernst, K. Kruger, R. Lindigkeit, H.M. Schiebel, T. Beuerle. Synthetic cannabinoids in 'spice-like' herbal blends: first appearance of JWH-307 and recurrence of JWH-018 on the German market. Forensic Sci. Int. 2012, 222, 216.
16. NMS Labs. Designer Drug Testing at NMS Labs, February 2014. Available at http://www.nmslabs.com/uploads/PDF/Designer_Drug_Trends_February_2014.pdf [11 July 2014].